Olema Pharmaceuticals, Inc.
OLMANASDAQHealthcareBiotechnology
As of Oct 26, 2026 close
- Market cap
- $691.48M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $6.48$36.26
- Volume (live)
- -
- Avg. volume (3M)
- 1.38M
Olema Pharmaceuticals (OLMA) Stock Price & Financial Analysis
Olema Pharmaceuticals Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $6.34 - $6.78 |
|---|---|
| 52-Week High | $36.26 |
| 52-Week Low | $6.48 |
| Open | $6.44 |
| Volume (last close) | 1.99M |
| Average Volume (3M) | 1.38M |
| 50-Day MA | $9.43 |
|---|---|
| 200-Day MA | $14.83 |
| 1-Year Change | −13.23% |
| Market Cap | 691.48M |
|---|---|
| Shares Outstanding | 104.45M |
| Price to Book (P/B) | 1.61 |
| EV/EBITDA | -3.25 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 26, 2026. Data sources and methodology
Olema Pharmaceuticals at a Glance
As of the Oct 26, 2026 close, Olema Pharmaceuticals (OLMA) has a market capitalization of $691.48M.
As of its latest reported balance sheet, it holds $48.60M in cash and securities against $3.66M of debt, a net cash position of $44.94M.
Olema Pharmaceuticals does not currently pay a dividend.
The share price is down 13.2% over the past year. At $6.62 (the Oct 26, 2026 close) it sits near the bottom of its 52-week range of $6.48 to $36.26, below its 200-day moving average of $14.83.
Based on 9 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $33.17, 401.1% above the Oct 26, 2026 close.
Frequently Asked Questions About Olema Pharmaceuticals
What is the current stock price for OLMA?
As of the Oct 26, 2026 close, OLMA stock trades at $6.62. The 52-week range is $6.48–$36.26, with a day range of $6.34–$6.78.
What is the P/E ratio for OLMA?
The P/E ratio (Price-to-Earnings) for OLMA is shown in the Key Statistics section. This valuation metric helps compare Olema Pharmaceuticals, Inc. to industry peers.
Does OLMA pay dividends?
Olema Pharmaceuticals does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for OLMA?
Based on ratings from 9 professional analysts over the last 90 days, the consensus for OLMA is Buy. The average 12-month price target is $33.17, a 401.1% upside from the Oct 26, 2026 close of $6.62.
What is the market cap of OLMA?
As of the Oct 26, 2026 close, Olema Pharmaceuticals's market capitalization is $691.5M, classifying it as a small-cap company. Olema Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.